CN113575944A - 具有驱除弓形虫功效的食品添加剂及其制备方法和应用 - Google Patents
具有驱除弓形虫功效的食品添加剂及其制备方法和应用 Download PDFInfo
- Publication number
- CN113575944A CN113575944A CN202110730378.7A CN202110730378A CN113575944A CN 113575944 A CN113575944 A CN 113575944A CN 202110730378 A CN202110730378 A CN 202110730378A CN 113575944 A CN113575944 A CN 113575944A
- Authority
- CN
- China
- Prior art keywords
- parts
- food additive
- raw materials
- toxoplasma gondii
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013373 food additive Nutrition 0.000 title claims abstract description 69
- 239000002778 food additive Substances 0.000 title claims abstract description 69
- 241000223997 Toxoplasma gondii Species 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 47
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 19
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 19
- 235000008434 ginseng Nutrition 0.000 claims abstract description 19
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims abstract description 18
- 244000197580 Poria cocos Species 0.000 claims abstract description 18
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 18
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 17
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 17
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 17
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 17
- 235000006533 astragalus Nutrition 0.000 claims abstract description 17
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 16
- 235000011477 liquorice Nutrition 0.000 claims abstract description 16
- 230000001846 repelling effect Effects 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims description 23
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 20
- 238000000605 extraction Methods 0.000 claims description 11
- 241000305491 Gastrodia elata Species 0.000 claims description 9
- 244000046146 Pueraria lobata Species 0.000 claims description 8
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- 235000013305 food Nutrition 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 5
- 241000209020 Cornus Species 0.000 claims 5
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 240000006766 Cornus mas Species 0.000 abstract description 12
- 230000001737 promoting effect Effects 0.000 abstract description 12
- 241000223996 Toxoplasma Species 0.000 abstract description 10
- 230000006870 function Effects 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 5
- 210000000056 organ Anatomy 0.000 abstract description 5
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 28
- 238000012360 testing method Methods 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- 210000000952 spleen Anatomy 0.000 description 15
- 240000004371 Panax ginseng Species 0.000 description 13
- 210000004072 lung Anatomy 0.000 description 13
- 230000007812 deficiency Effects 0.000 description 12
- 230000027939 micturition Effects 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 8
- 230000001976 improved effect Effects 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 206010003549 asthenia Diseases 0.000 description 6
- 235000015872 dietary supplement Nutrition 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 5
- 206010062519 Poor quality sleep Diseases 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 208000006673 asthma Diseases 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 201000001881 impotence Diseases 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010012374 Depressed mood Diseases 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 208000012886 Vertigo Diseases 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 208000024963 hair loss Diseases 0.000 description 3
- 208000034783 hypoesthesia Diseases 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 210000001539 phagocyte Anatomy 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 231100000889 vertigo Toxicity 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 2
- 208000031091 Amnestic disease Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010034568 Peripheral coldness Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 206010070863 Toxicity to various agents Diseases 0.000 description 2
- 230000006986 amnesia Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 210000000750 endocrine system Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000004932 little finger Anatomy 0.000 description 2
- 210000005075 mammary gland Anatomy 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 206010039083 rhinitis Diseases 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- ACTOXUHEUCPTEW-BWHGAVFKSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2s,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BWHGAVFKSA-N 0.000 description 1
- 206010000090 Abdominal rigidity Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 240000000530 Alcea rosea Species 0.000 description 1
- 235000017334 Alcea rosea Nutrition 0.000 description 1
- 235000017303 Althaea rosea Nutrition 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003805 Autism Diseases 0.000 description 1
- 208000020706 Autistic disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 208000024806 Brain atrophy Diseases 0.000 description 1
- 206010006272 Breast mass Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 241001660870 Cyrtomium Species 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 241001673966 Magnolia officinalis Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000023178 Musculoskeletal disease Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 206010034912 Phobia Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 206010039987 Senile psychosis Diseases 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010064127 Solar lentigo Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 239000004187 Spiramycin Substances 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 244000057214 Stachys sieboldii Species 0.000 description 1
- 235000005116 Stachys sieboldii Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046798 Uterine leiomyoma Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002531 effect on toxoplasma Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000008029 eradication Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 244000000056 intracellular parasite Species 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 208000018944 leg cramp Diseases 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000019899 phobic disease Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- WKSAUQYGYAYLPV-UHFFFAOYSA-N pyrimethamine Chemical compound CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1 WKSAUQYGYAYLPV-UHFFFAOYSA-N 0.000 description 1
- 229960000611 pyrimethamine Drugs 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 230000036578 sleeping time Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 229960001294 spiramycin Drugs 0.000 description 1
- 235000019372 spiramycin Nutrition 0.000 description 1
- 229930191512 spiramycin Natural products 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000003812 trophozoite Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 206010047470 viral myocarditis Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明公开了一种具有驱除弓形虫功效的食品添加剂及其制备方法和应用,所述食品添加剂由如下重量份原料制得:茯苓15~25份、葛根12~18份、天麻8~12份、山茱萸8~12份、当归8~12份、人参2~4份、黄精8~12份、甘草8~12份、黄芪8~12份和冬虫夏草1~3份。本申请上述食品添加剂通过各原料以及用量配比的限定,使得制备得到的食品添加剂能够吸引弓形虫脱离细胞,并通过改善机体免疫力、提高各器官功能以及促进机体的新陈代谢,达到快速驱除弓形虫的目的。
Description
技术领域
本发明涉及中药食品技术领域,具体涉及一种具有驱除弓形虫功效的食品添加剂及其制备方法和应用。
背景技术
弓形虫是世界卫生组织公认的,“一种传播性强,危害极大的病原体”,它是一种细胞内的寄生虫,人群中普遍的感染率较高,80%的人身体里都有这种寄生虫。弓形虫寄生于细胞内不但不能被各种吞噬细胞融化掉,反而可以在各种吞噬细胞内繁殖,使吞噬细胞失去吞噬能力,从而破坏身体各个脏器组织,造成内分泌、心脑血管、神经性系统等疾病。
比如,对神经系统造成的的危害:儿童的多动症,自闭症,自残症,恐惧症;老年人的痴呆症,脑萎缩,老年精神病;成年人的神经衰弱,神经官能症,意病,抑郁症,精神分裂症,性功能亢奋,性无能等等。对人体各器管,各组织造成的危害:头颅,心,肝,脾,肺,肾,五脏的疾病;肺,胃,大肠小肠膀胱,子宫卵巢,前列腺等泌尿生殖系统疾病;脑中风,高血压,糖尿病,人体的五脏六腑,肌肉骨骼病症,血液病,各种肿瘤,癌症等等。
随着人民生活水平的提高,对健康越来越重视,弓形虫对人体的危害也逐渐被大家所认知。目前国际上有很多机构在研究与治疗弓形虫,西医的治疗方法以抗生素为主,至今发现可以抑制弓形虫的药物有:乙胺嘧定、磺胺、四环素族药物、螺旋霉素等。这些药物都能抑制弓形虫滋养体,但对包囊无效,如果长时间使用,会产生药毒性,达不到治愈弓形虫的目的。中医治疗方法:古中医书中有记载:用厚朴、贯众、僵蚕、石蚕、狼毒、蜀漆等用以毒攻毒的方法,此方法,对人体的肠胃会引起不良反应,甚至会对肠胃组织,造成很大的伤害!
发明内容
本发明的目的在于提供一种具有驱除弓形虫功效的食品添加剂及其制备方法和应用,该食品添加剂能够降低弓形虫活性,有利于从细胞内将其驱除,从而解决了由于弓形虫感染引起的各类问题。
为了实现本发明的上述目的,特采用以下技术方案:
本发明第一方面提供一种具有驱除弓形虫功效的食品添加剂,所述食品添加剂由如下重量份原料制得:
茯苓15~25份、葛根12~18份、天麻8~12份、山茱萸8~12份、当归8~12 份、人参2~4份、黄精8~12份、甘草8~12份、黄芪8~12份和冬虫夏草1~3 份。
在本发明中采用的各原料如下:
茯苓:味甘、淡,性平;归心、肺、脾、肾经;具有利水渗湿、健脾、宁心等功效;用于水肿尿少、痰饮眩悸、脾虚食少、便溏泄泻、心神不安、惊悸失眠等症。
葛根:味甘、辛,性凉;归肺、胃经;具有解肌退热、透疹、生津止渴、升阳止泻等功效;用于表证发热、项背强痛、麻疹不透、热病口渴、阴虚消渴、热泻热痢、脾虚泄泻等症。
天麻:性平,味丹;归肝经;具有平肝息风、止痉等功效;用治头痛眩晕、肢体麻木、小儿惊风、癫痫抽搐、破伤风等症。天麻浸膏及水煎液有镇静、镇痛、抗惊厥作用;天麻多糖有增强实验动物机体非特异性免疫及细胞免疫和抗炎作用。另有延缓衰老,抑制血小板聚集,保护心肌细胞等作用。
山茱萸:性微温,味酸、涩;归肝经、肾经;具有补益肝肾、收涩固脱等功效;用于眩晕耳呜,腰膝酸痛,阳痿遗精,遗尿尿频,崩漏带下,大汗虚脱,内热消渴。药理研究表明,其具有增强免疫系统功能、抗炎、抗失血性休克、降血糖、抑制血小板聚集、改善心功能及血流动力学、抗菌、利尿等。
当归:性温,味甘、辛;归肝经、心经、脾经;具有补血活血、调经止痛、润肠通便等功效;用治血虚萎黄、眩晕心悸、月经不调、经闭痛经、虚寒腹痛、肠燥便秘、风湿痹痛、跌扑损伤、痈疽疮疡。
人参:性温,味甘、微苦;归心经、肺经、脾经、肾经;具有大补元气、复脉固脱、补脾益肺、生津安神等功效;治疗体虚欲脱、气短喘促、自汗肢冷、精神倦怠、食少吐泻、气虚作喘或久咳、津亏口渴、消渴、失眠多梦、惊悸健忘、阳痿、尿频、一切气血津液不足之症。人参对中枢神经系统有双向调节、促智、镇痛、解热、抗惊和肌力减弱等作用。对心血管系统有强心、抗缺血、扩张血管、降压等作用;对血液系统有保护和刺激造血功能,并抗凝血和抗血栓;对内分泌系统有促皮质激素样、促性激素样作用。
黄精:性平,味甘;归肺经、脾经、肾经;具有补气养阴、健脾、润肺、益肾等功效;用治脾胃虚弱、体倦乏力、口干食少、肺虚燥咳、精血不足、内热消渴。
甘草:性平,味甘;归心经、胃经、脾经、肺经;具有补脾益气、止咳祛痰、缓急定痛、调和药性等功效;治疗脾胃虚弱、中气不足、咳嗽气喘、痈疽疮毒、腹中挛急作痛、缓和药物烈性、解药毒。清热应生用,补中宜炙用。实证中满腹胀者忌服。
黄芪:性微温,味甘;归脾经、肺经;具有补气固表、利尿、托毒排脓、生肌等功效;治疗气短心悸、乏力、虚脱、自汗、盗汗、体虚浮肿、慢性肾炎、久泻、脱肛、子宫脱垂、痈疽难溃、疮口久不愈合、小儿支气管哮喘、慢性乙型肝炎、慢性肾炎和病毒性心肌炎。补气宜炙用,止汗、利尿、托毒排脓生肌宜生用。
冬虫夏草:性平,味甘;归肺经、肾经;具有补肺益肾、止血,化痰等功效;用治久咳虚喘、劳嗽咯血、阳痿遗精、腰膝酸痛。此外,还具有调节免疫功能,有使免疫功能增强或减弱的双相调节作用;具有较强的抗癌作用;使心率减慢,但心输出量却显著增加;对支气管平滑肌有明显的扩张作用,有平喘和祛痰作用;可使空腹血糖升高;影响内分泌系统,还有抗炎、镇静及抗惊厥作用;具有一定的抗菌作用,能保护肾功能,还具有防辐射、抗突变的作用;能提高细胞吞噬功能,增强心血管和机体免疫机能,还具有抗心律失常等功能。
本申请上述食品添加剂通过各原料以及用量配比的限定,使得制备得到的食品添加剂能够吸引弓形虫脱离细胞,并通过改善机体免疫力,提高各器官功能,促进机体的新陈代谢,达到快速驱除弓形虫的目的。
优选地,所述食品添加剂由如下重量份原料制得:
茯苓18~22份、葛根14~16份、天麻8~10份、山茱萸10~12份、当归10~12 份、人参3~4份、黄精8~10份、甘草8~10份、黄芪10~12份和冬虫夏草1~2 份。
优选地,所述食品添加剂由如下重量份原料制得:
茯苓20份、葛根15份、天麻10份、山茱萸10份、当归10份、人参3份、黄精10份、甘草10份、黄芪10份和冬虫夏草2份。
优选地,所述食品添加剂由如下重量份原料制得:
茯苓18份、葛根14份、天麻10份、山茱萸10份、当归12份、人参4份、黄精8份、甘草10份、黄芪12份和冬虫夏草2份。
优选地,所述食品添加剂由如下重量份原料制得:
茯苓22份、葛根16份、天麻8份、山茱萸12份、当归10份、人参3份、黄精10份、甘草8份、黄芪10份和冬虫夏草1份。
本发明第二方面提供一种上述食品添加剂的制备方法,所述制备方法包括如下步骤:
(a)按重量份计,称取各原料并混合,得到混合原料;
(b)采用超临界流体萃取法对混合原料进行萃取,即得所述食品添加剂,其中,超临界流体萃取法采用的萃取剂为CO2。
优选地,所述超临界流体萃取法的萃取温度为10~18℃,压力为8.5~15MPa。
在本发明中,通过选择特定的萃取方法以及超临界流体萃取的控制参数,能够使得萃取得到的食品添加剂具有更加优异的驱除弓形虫的功效。
本发明第三方面提供一种上述食品添加剂在制备具有驱除弓形虫功效的食品或药品中的应用。
本发明第四方面提供一种具有驱除弓形虫功效的食品,所述食品包括上述食品添加剂。
与现有技术相比,本发明的有益效果至少包括:
本申请上述食品添加剂通过各原料以及用量配比的限定,使得制备得到的食品添加剂能够吸引弓形虫脱离细胞,并通过改善机体免疫力、提高各器官功能以及促进机体的新陈代谢,达到快速驱除弓形虫的目的;本发明食品添加剂选择药食同源原料,其具有安全可靠,无任何毒副作用。
本申请上述制备方法通过对超临界萃取的温度以及压力的控制,使得萃取得到的食品添加剂具有对弓形虫更好的驱除效果。
附图说明
为了更清楚地说明本发明具体实施方式或现有技术中的技术方案,下面将对具体实施方式或现有技术描述中所需要使用的附图作简单地介绍。在所有附图中,类似的元件或部分一般由类似的附图标记标识。附图中,各元件或部分并不一定按照实际的比例绘制。
图1本发明实验例中第1组第1名患者服用前检测结果;
图2本发明实验例中第1组第1名患者服用后检测结果;
图3本发明实验例中第1组第2名患者服用前检测结果;
图4本发明实验例中第1组第2名患者服用后检测结果;
图5本发明实验例中第2组第1名患者服用前检测结果;
图6本发明实验例中第2组第1名患者服用后检测结果;
图7本发明实验例中第2组第2名患者服用前检测结果;
图8本发明实验例中第2组第2名患者服用后检测结果;
图9本发明实验例中第3组第1名患者服用前检测结果;
图10本发明实验例中第3组第1名患者服用后检测结果;
图11本发明实验例中第3组第2名患者服用前检测结果;
图12本发明实验例中第3组第2名患者服用后检测结果;
图13本发明实验例中第4组第1名患者服用前检测结果;
图14本发明实验例中第4组第1名患者服用后检测结果;
图15本发明实验例中第4组第2名患者服用前检测结果;
图16本发明实验例中第4组第2名患者服用后检测结果;
图17本发明实验例中第5组第1名患者服用前检测结果;
图18本发明实验例中第5组第1名患者服用后检测结果;
图19本发明实验例中第5组第2名患者服用前检测结果;
图20本发明实验例中第5组第2名患者服用后检测结果;
图21本发明实验例中第6组第1名患者服用前检测结果;
图22本发明实验例中第6组第1名患者服用后检测结果;
图23本发明实验例中第6组第2名患者服用前检测结果;
图24本发明实验例中第6组第2名患者服用后检测结果。
具体实施方式
下面将结合实施例对本发明技术方案的实施例进行详细的描述。以下实施例仅用于更加清楚地说明本发明的技术方案,因此只作为示例,而不能以此来限制本发明的保护范围。
需要注意的是,除非另有说明,本申请使用的技术术语或者科学术语应当为本发明所属领域技术人员所理解的通常意义。
实施例1
一、具有驱除弓形虫功效的食品添加剂
上述具有驱除弓形虫功效的食品添加剂由如下重量份原料制得:
茯苓15份、葛根18份、天麻8份、山茱萸12份、当归12份、人参2份、黄精12份、甘草8份、黄芪8份和冬虫夏草3份。
二、制备方法
上述具有驱除弓形虫功效的食品添加剂的制备方法,该制备方法包括如下步骤:
(a)按重量份计,称取各原料并混合,得到混合原料;
(b)采用超临界流体萃取法对混合原料进行萃取,即得上述食品添加剂,其中,超临界流体萃取法采用的萃取剂为CO2,萃取温度为10℃,压力为15MPa。
实施例2
一、具有驱除弓形虫功效的食品添加剂
上述具有驱除弓形虫功效的食品添加剂由如下重量份原料制得:
茯苓25份、葛根12份、天麻12份、山茱萸8份、当归8份、人参4份、黄精8份、甘草12份、黄芪12份和冬虫夏草1份。
二、制备方法
上述具有驱除弓形虫功效的食品添加剂的制备方法,该制备方法包括如下步骤:
(a)按重量份计,称取各原料并混合,得到混合原料;
(b)采用超临界流体萃取法对混合原料进行萃取,即得上述食品添加剂,其中,超临界流体萃取法采用的萃取剂为CO2,萃取温度为18℃,压力为 8.5MPa。
实施例3
一、具有驱除弓形虫功效的食品添加剂
上述具有驱除弓形虫功效的食品添加剂由如下重量份原料制得:
茯苓22份、葛根16份、天麻8份、山茱萸12份、当归10份、人参3份、黄精10份、甘草8份、黄芪10份和冬虫夏草1份。
二、制备方法
上述具有驱除弓形虫功效的食品添加剂的制备方法,该制备方法包括如下步骤:
(a)按重量份计,称取各原料并混合,得到混合原料;
(b)采用超临界流体萃取法对混合原料进行萃取,即得上述食品添加剂,其中,超临界流体萃取法采用的萃取剂为CO2,萃取温度为15℃,压力为12MPa。
实施例4
一、具有驱除弓形虫功效的食品添加剂
上述具有驱除弓形虫功效的食品添加剂由如下重量份原料制得:
茯苓18份、葛根14份、天麻10份、山茱萸10份、当归12份、人参4 份、黄精8份、甘草10份、黄芪12份和冬虫夏草2份。
二、制备方法
上述具有驱除弓形虫功效的食品添加剂的制备方法,该制备方法包括如下步骤:
(a)按重量份计,称取各原料并混合,得到混合原料;
(b)采用超临界流体萃取法对混合原料进行萃取,即得上述食品添加剂,其中,超临界流体萃取法采用的萃取剂为CO2,萃取温度为15℃,压力为12MPa。
实施例5
一、具有驱除弓形虫功效的食品添加剂
上述具有驱除弓形虫功效的食品添加剂由如下重量份原料制得:
茯苓20份、葛根15份、天麻10份、山茱萸10份、当归10份、人参3 份、黄精10份、甘草10份、黄芪10份和冬虫夏草2份。
二、制备方法
上述具有驱除弓形虫功效的食品添加剂的制备方法,该制备方法包括如下步骤:
(a)按重量份计,称取各原料并混合,得到混合原料;
(b)采用超临界流体萃取法对混合原料进行萃取,即得上述食品添加剂,其中,超临界流体萃取法采用的萃取剂为CO2,萃取温度为15℃,压力为12MPa。
对比例1
本对比例为一种具有驱除弓形虫功效的食品添加剂,该食品添加剂与实施例5中的食品添加剂基本相同,区别仅在于将天麻替换为同等分数的黄芪;
上述食品添加剂的制备方法同实施例5中的制备方法。
对比例2
本对比例为一种具有驱除弓形虫功效的食品添加剂,该食品添加剂与实施例5中的食品添加剂基本相同,区别仅在于将冬虫夏草替换为同等分数的人参;
上述食品添加剂的制备方法同实施例5中的制备方法。
对比例3
本对比例为一种具有驱除弓形虫功效的食品添加剂,该食品添加剂与实施例5中的食品添加剂原料组分相同;区别仅在于,该食品添加剂通过如下方法制得:
(a)按重量份计,称取各原料并混合,得到混合原料;
(b)采用超临界流体萃取法对混合原料进行萃取,即得上述食品添加剂,其中,超临界流体萃取法采用的萃取剂为CO2,萃取温度为15℃,压力为18MPa。
实验例
分别获取实施例3~5以及对比例1~3中的食品添加剂;
选取弓形虫感染者12位并随机分为6组,每组2位,其中,将6组患者分别服用实施例3~5以及对比例1~3中的食品添加剂进行弓形虫的驱除,服用方法为口服,每天早晚各一次,每次50g,持续服用20天;
采用血液检测方法分别检测每位患者服用食品添加剂前后的弓形虫数量,并计算每位患者的弓形虫驱除率,计算公式为驱除率=服用食品添加剂后的弓形虫数量/服用食品添加剂前的弓形虫数量×100%;
第1组(服用实施例5的食品添加剂组)2名患者情况如下:
第1名:陈某某,女,年龄45岁;服用前具有面部肝斑较多,腰椎盘突出,左手小指麻木,胃胀气,乳腺增生,整个人浮肿,睡眠差;服用后左手小指麻木基本好了,整个人紧实了很多,例假前后,乳腺胀痛感减弱很多;
第2名:唐某,女,42岁;服用前具有子宫肌瘤,例假量少,面色苍白,说话无力,湿气很重,腰痛,颈椎痛,食欲不佳,睡眠不好,腹胀;服用后睡眠改善,排气后腹胀问题解决,食欲增加,例假量明显增加,且无腹痛感。
第2组(服用实施例3的食品添加剂组)2名患者情况如下:
第1名:赵某,男,45岁;服用前具有睡眠不好,前列腺有问题,小腿容易抽筋,盗汗,半夜偶有干咳,血脂高;服用后咳嗽基本没有了,血脂有微微下降。
第2名:林某,女,38岁;服用前面色发青,小腿静脉曲张,腰痛,睡眠多梦,易半夜惊醒,月经量少,时间无规律;服用后小腿浮肿减弱。
第3组(服用实施例4的食品添加剂组)2名患者情况如下:
第1名:吴某,男,35岁;服用前易出汗、肠胃不好、压力大就拉肚子、肌肉紧张、心跳快、睡眠差,口干;服用后大便改善,基本不盗汗,睡眠有一点改善。
第2名:邓某某,男,20岁;服用前胡思乱想、经常整夜不睡、不想吃饭,体重直线下降,经常怀疑他人;服用后喜欢跟人沟通了,睡眠越来越好,入睡比较容易。
第4组(服用对比例1的食品添加剂组)2名患者情况如下:
第1名:杜某某,男,48岁;服用前虚胖、肾虚、三高、记忆力减退、运动易扭伤、尿频尿急、耳鸣;服用后尿频尿急得到缓解,耳鸣基本消除。
第2名:王某,男,68岁;服用前睡眠不好,胃口不佳,长期有口腔溃疡,三高、腰腿痛、骨质疏松、尿频;服用后睡眠改善,入睡容易很多,睡眠时长也增加了不少,尿频问题稍微有所改善,腰痛减轻很多。
第5组(服用对比例2的食品添加剂组)2名患者情况如下:
第1名:肖某某,女,59岁;服用前睡眠不佳,左膝走路痛,没有食欲,胆结石,情绪低落,烦躁、健忘、气虚乏力,偏头痛;服用后记忆力有所改善,睡眠好很多,偏头疼次数明显减少。
第2名:崔某,男,45岁;服用前失眠、入睡难,食欲不佳,讲课没力气,容易感冒,特别冬天会气喘,手脚凉、掉发;服用后面色红润了,睡眠更深了,气血整体都有变化,掉发情况缓解了很多。
第6组(服用对比例3的食品添加剂组)2名患者情况如下:
第1名:王某某,女,28岁;服用前乳腺增生、长期困乏、情绪低落、喜欢吃糖多的食品、偶有胸闷、鼻炎;服用后精神好了很多,喜欢运动了,鼻炎缓解了一些。
第2名:王某,女,50岁;服用前更年期各种症状,失眠、焦虑、情绪低落、一直靠安眠药维持睡眠,尿频,乳腺结节等;服用后情绪好了很多,特别是焦虑得到明显改善,心情变化很大,尿频也所有缓解,入睡容易很多,睡眠所有改善。
以上每位患者弓形虫的检测图以及驱除率如表1所示:
表1每位患者弓形虫的检测图以及驱除率
由表1可知;本申请要求保护的食品添加剂通过各原料的选择能够更好地驱除弓形虫,其驱出率最高可达96%。
最后应说明的是:以上各实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述各实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的范围,其均应涵盖在本发明的权利要求和说明书的范围当中。
Claims (9)
1.一种具有驱除弓形虫功效的食品添加剂,其特征在于,由如下重量份原料制得:
茯苓15~25份、葛根12~18份、天麻8~12份、山茱萸8~12份、当归8~12份、人参2~4份、黄精8~12份、甘草8~12份、黄芪8~12份和冬虫夏草1~3份。
2.根据权利要求1所述的食品添加剂,其特征在于,由如下重量份原料制得:
茯苓18~22份、葛根14~16份、天麻8~10份、山茱萸10~12份、当归10~12份、人参3~4份、黄精8~10份、甘草8~10份、黄芪10~12份和冬虫夏草1~2份。
3.根据权利要求1所述的食品添加剂,其特征在于,由如下重量份原料制得:
茯苓20份、葛根15份、天麻10份、山茱萸10份、当归10份、人参3份、黄精10份、甘草10份、黄芪10份和冬虫夏草2份。
4.根据权利要求1所述的食品添加剂,其特征在于,由如下重量份原料制得:
茯苓18份、葛根14份、天麻10份、山茱萸10份、当归12份、人参4份、黄精8份、甘草10份、黄芪12份和冬虫夏草2份。
5.根据权利要求1所述的食品添加剂,其特征在于,由如下重量份原料制得:
茯苓22份、葛根16份、天麻8份、山茱萸12份、当归10份、人参3份、黄精10份、甘草8份、黄芪10份和冬虫夏草1份。
6.权利要求1~5任一所述的食品添加剂的制备方法,其特征在于,包括如下步骤:
(a)按重量份计,称取各原料并混合,得到混合原料;
(b)采用超临界流体萃取法对混合原料进行萃取,即得所述食品添加剂,其中,超临界流体萃取法采用的萃取剂为CO2。
7.根据权利要求6所述的制备方法,其特征在于,所述超临界流体萃取法的萃取温度为10~18℃,压力为8.5~15MPa。
8.权利要求1~5任一所述的食品添加剂在制备具有驱除弓形虫功效的食品或药品中的应用。
9.一种具有驱除弓形虫功效的食品,其特征在于,所述食品包括权利要求1~5任一所述的食品添加剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110730378.7A CN113575944A (zh) | 2021-06-29 | 2021-06-29 | 具有驱除弓形虫功效的食品添加剂及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110730378.7A CN113575944A (zh) | 2021-06-29 | 2021-06-29 | 具有驱除弓形虫功效的食品添加剂及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113575944A true CN113575944A (zh) | 2021-11-02 |
Family
ID=78245236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110730378.7A Pending CN113575944A (zh) | 2021-06-29 | 2021-06-29 | 具有驱除弓形虫功效的食品添加剂及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113575944A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114569677A (zh) * | 2022-03-18 | 2022-06-03 | 深圳市中畅康健有限公司 | 一种治疗抑郁症的中药配方 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105311429A (zh) * | 2015-11-19 | 2016-02-10 | 郝艳 | 一种养生保健补中药 |
CN108498665A (zh) * | 2018-06-13 | 2018-09-07 | 傅体委 | 一种治疗体内寄生虫的药物组方 |
CN108902968A (zh) * | 2018-06-20 | 2018-11-30 | 北京刚地源弓形虫病医学研究院 | 一种驱除弓形虫的药食同源食品添加配方及其制备方法 |
CN109908265A (zh) * | 2019-03-25 | 2019-06-21 | 珠海汉唐生物科技工程有限公司 | 抑制驱除弓形虫、弓形虫胞囊体的口服液及其制备方法 |
CN111135253A (zh) * | 2020-01-16 | 2020-05-12 | 珠海汉唐生物科技工程有限公司 | 一种清除弓形虫寄生态的配方及其胶囊的制造方法 |
-
2021
- 2021-06-29 CN CN202110730378.7A patent/CN113575944A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105311429A (zh) * | 2015-11-19 | 2016-02-10 | 郝艳 | 一种养生保健补中药 |
CN108498665A (zh) * | 2018-06-13 | 2018-09-07 | 傅体委 | 一种治疗体内寄生虫的药物组方 |
CN108902968A (zh) * | 2018-06-20 | 2018-11-30 | 北京刚地源弓形虫病医学研究院 | 一种驱除弓形虫的药食同源食品添加配方及其制备方法 |
CN109908265A (zh) * | 2019-03-25 | 2019-06-21 | 珠海汉唐生物科技工程有限公司 | 抑制驱除弓形虫、弓形虫胞囊体的口服液及其制备方法 |
CN111135253A (zh) * | 2020-01-16 | 2020-05-12 | 珠海汉唐生物科技工程有限公司 | 一种清除弓形虫寄生态的配方及其胶囊的制造方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114569677A (zh) * | 2022-03-18 | 2022-06-03 | 深圳市中畅康健有限公司 | 一种治疗抑郁症的中药配方 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104147552A (zh) | 一种治疗血瘀型产后腹痛的中药组合物及其制备方法 | |
CN102988701A (zh) | 一种用于治疗便秘的中药及其制备工艺 | |
CN102908474B (zh) | 一种治疗神经官能症的药酒 | |
CN107137499A (zh) | 一种调理身体补充元气的热敷粉包 | |
CN113575944A (zh) | 具有驱除弓形虫功效的食品添加剂及其制备方法和应用 | |
CN103816454A (zh) | 一种治疗动脉硬化的纯中药胶囊 | |
CN103656048B (zh) | 用于治疗奶牛乳房炎的药物及其制备方法 | |
CN103463467B (zh) | 一种具有滋补肾阴功效的苗方药酒 | |
CN102293964A (zh) | 一种治疗胃溃疡的药物及其制备方法 | |
CN106110008A (zh) | 一种治疗产后抑郁症的中药制剂及制备方法 | |
CN105998555A (zh) | 一种用于产后关节痛缓解与护理的中药丸剂及制备方法 | |
CN104857370A (zh) | 一种治疗乳腺癌症的中药组合物 | |
CN104606661A (zh) | 一种治疗剖宫产后缺乳的中药催乳剂及其制备方法 | |
CN103341054B (zh) | 一种治疗心脑血管疾病的中药制剂及制备方法 | |
CN103393927B (zh) | 一种治疗更年期综合症的药物及其制备方法 | |
CN105288298A (zh) | 一种用于脑动脉瘤后遗症的中药制剂及其制备方法 | |
CN106511806A (zh) | 一种治疗癔症的药物及其制备方法 | |
CN104784608B (zh) | 改善肿瘤化疗后毒副反应的药物的制备方法 | |
CN104436060A (zh) | 一种护理治疗胆管细胞癌的中药配方及其制备方法 | |
CN104800724B (zh) | 改善肿瘤化疗后毒副反应的药物 | |
CN105362669A (zh) | 一种治疗流行性出血热的缓释片及其制备方法 | |
CN105434987A (zh) | 一种治疗脑梗塞的中药制剂 | |
CN105267895A (zh) | 用于治疗牛产后血瘀型胞衣不下的药物及其制备方法 | |
CN114617936A (zh) | 一种驱弓形虫的药食同源五精压片糖果及其制备方法 | |
CN104258125A (zh) | 一种治疗产后贫血的中药药丸 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211102 |
|
RJ01 | Rejection of invention patent application after publication |